| Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Determinants of transdermal drug delivery to the normal and the radiated breast |
5R01CA235647-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Kelleher, Sarah |
Duke University
United States |
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings |
5R21CA273832-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Katona, Bryson William |
University Of Pennsylvania
United States |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
5R21CA267949-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Asad Umar, D.V.M., Ph.D. |
| Kassie, Fekadu |
University Of Minnesota
United States |
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells |
5R01CA231210-05 |
|
Marjorie Perloff, M.D. |
| Kanwal, Fasiha |
Baylor College Of Medicine
United States |
Risk Stratification for and Early Detection of Liver Cancer |
2U01CA230997-06 |
|
Sidney Fu, M.D. |
| Kalluri, Raghu |
University Of Tx Md Anderson Can Ctr
United States |
Rigorous and reproducible mutational analysis of the urinary exosomal DNA |
5R01CA231465-05 |
|
|
| Kahalley, Lisa Schum |
Baylor College Of Medicine
United States |
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy |
5R01CA221197-05 |
|
|
| Kahalley, Lisa Schum |
Baylor College Of Medicine
United States |
Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy. |
3R01CA249988-03S1 |
|
|
| Kachnic, Lisa A. |
Columbia University Health Sciences
United States |
Columbia University Minority/Underserved Site NCI Community Oncology Research Program |
5UG1CA189960-10 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Johnson, Constance Margaret |
University Of Texas Hlth Sci Ctr Houston
United States |
The relationship between fMRI and patient-reported outcomes in chemotherapy-induced neuropathy: A diversity supplement |
3R01CA245054-04S1 |
|
Rachel Altshuler, Ph.D. |